HHS Office for Human Research Protections
This article was originally published in The Tan Sheet
Executive Summary
FDA Senior Advisor for Science Bernard Schwetz, PhD, leaves agency to take over OHRP effective Feb. 3. In his new role, Schwetz will "help coordinate OHRP and FDA efforts to assure that all human research and clinical studies are conducted properly," FDA Commissioner Mark McClellan, MD/PhD, says Jan. 31. Schwetz served as FDA acting commissioner for roughly one year beginning in January 2001...